Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 53.06 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 53.70 | Oscillator | Neutral |
| Williams %R (14) | -36.11 | Oscillator | Neutral |
| MACD (12, 26, 9) | -0.00 (Hist 0.01) | Oscillator | Buy |
| Average Directional Index (14) | 12.65 (+DI 18.6 / -DI 18.8) | Trend | Neutral |
| EMA 20 | 2.87 | MA | Buy |
| SMA 20 | 2.84 | MA | Buy |
| EMA 50 | 2.90 | MA | Buy |
| SMA 50 | 2.90 | MA | Buy |
| SMA 200 | 3.05 | MA | Strong Sell |
Current price $2.92
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Jul 27, 26 | RBC Capital | maintain | Outperform | Outperform |
| Jul 27, 26 | Truist Securities | maintain | Hold | Hold |
| Jul 24, 26 | UBS | maintain | Neutral | Neutral |
| Jul 23, 26 | Barclays | maintain | Underweight | Underweight |
| Jul 14, 26 | Truist Securities | maintain | Hold | Hold |
| Jul 8, 26 | Barclays | downgrade | Equal Weight | Underweight |
| Apr 23, 26 | Barclays | maintain | Equal Weight | Equal Weight |
| Apr 23, 26 | Truist Securities | maintain | Hold | Hold |
| Apr 13, 26 | Truist Securities | maintain | Hold | Hold |
FY2025 · 10-K disclosure
Stock news · updated daily
FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (NYSE: CYH) today announced that it will webcast its third quarter 2026 conference call. The Company will issue a press release announcing its results on Wednesday, October 28, 2026, after the regular close of trading. The conference call is scheduled to begin at 10:00 a.m. Central Time, 11:00 a.m. Eastern Time, on Thursday, October 29, 2026. During this call, Community Health Systems will review the Company's financial and operat.
Community Health Systems, Inc. (NYSE: CYH) today announced that it will webcast its third quarter 2026 conference call.The Company will issue a press release an
Bank of America Corp DE purchased a new stake in Community Health Systems, Inc. (NYSE: CYH) during the undefined quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 1,767,619 shares of the company's stock, valued at approximately $5,904,000. Bank of America Corp DE owned 1.25%
CYH's volume growth faces pressure from softer elective procedures and payer mix, while a recovery in demand could help margins and cash flow.
Community Health Systems (NYSE: CYH - Get Free Report) and Cosmos Health (NASDAQ: COSM - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, analyst recommendations, risk, valuation, dividends and institutional ownership. Valuation and Earnings This table compares
Tenet, Acadia and Community Health Systems have been highlighted in this Industry Outlook article.
The Zacks Medical-Hospital operators are benefiting from steady care demand while sharpening efficiency and portfolio strategy. Investors may want to track THC, ACHC and CYH.
FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (“CHS”) (NYSE: CYH) released its 2026 Community Impact Report today, detailing some of the many ways the organization is improving healthcare quality and outcomes, supporting its workforce, and strengthening communities. “In healthcare, we have a daily opportunity to improve the human condition, which is both a worthwhile purpose and a profound responsibility,” said Kevin Hammons, Chief Executive Officer of Community Health System.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Jul 22, 2026 | -0.10 | -0.19 | Miss -83.4% | $2.83B |
| Apr 21, 2026 | -0.11 | -0.48 | Miss -323.1% | $2.96B |
| Feb 18, 2026 | -0.20 | -0.01 | Beat 95.1% | $3.11B |
| Oct 23, 2025 | -0.28 | 1.27 | Beat 557.4% | $3.09B |
| Jul 23, 2025 | 0.05 | -0.05 | Miss -200.0% | $3.13B |
| Apr 23, 2025 | -0.10 | -0.03 | Beat 70.0% | $3.16B |
TTM vs. 5-year historical average (annual ratios)
| Metric | CYH | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -1.3x | 3.3x · sector 20.7x | Discount |
| Forward P/E (FY26E) | -2.6x | EPS est. -1.13 | Elevated |
| Price / Book | -0.3x | -0.5x | Discount |
| Price / Sales | 0.0x | 0.1x | Discount |
| EV / EBITDA | 2.3x | 8.4x | Discount |
| Return on equity | 20.9% | — | Top tier |
| Gross margin | 58.1% | 34.5% | Above hist. |
| Debt / Equity | -7.34 | -8.36 | Conservative |
| Piotroski / Altman Z | 5/9 | Z 2.69 | Grey zone |
Discounted cash flow model
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Aug 25, 26 | Jennings William Norris | director | S-Sale | 40,000 @ $2.96 | $118.4K |
| Jun 30, 26 | Krishnan K Ranga | director | M-Exempt | 13,930 | — |
| Jun 30, 26 | Krishnan K Ranga | director | M-Exempt | 13,931 | — |
| Jun 1, 26 | Rice David V. | officer: EVP-Clinical Operations & CMO | A-Award | 30,000 @ $2.75 | $82.50K |
| Jun 1, 26 | Rice David V. | officer: EVP-Clinical Operations & CMO | A-Award | 30,000 | — |
| Jun 1, 26 | Rice David V. | officer: EVP-Clinical Operations & CMO | A-Award | 30,000 | — |
| May 12, 26 | Rice David V. | 0 | — | ||
| Apr 22, 26 | Krishnan K Ranga | director | M-Exempt | 46,950 | — |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 4 | Aug 25, 2026 | 2026-08-25 17:23:00 | View |
| SC 13G/A | Aug 10, 2026 | 2026-08-10 21:53:19 | View |
| 10-Q | Jul 23, 2026 | 2026-07-23 16:30:41 | View |
| 8-K | Jul 22, 2026 | 2026-07-22 16:33:42 | View |
| 4 | Jun 30, 2026 | 2026-06-30 16:56:04 | View |
| 4 | Jun 1, 2026 | 2026-06-01 17:38:23 | View |
| 8-K | Jun 1, 2026 | 2026-06-01 16:30:16 | View |
| SC 13G/A | May 15, 2026 | 2026-05-15 20:06:12 | View |
| SC 13G/A | May 15, 2026 | 2026-05-15 16:50:14 | View |
| 3 | May 14, 2026 | 2026-05-14 16:50:24 | View |
Proxy statement (DEF 14A) disclosures